Introduction
The endogenous creatinine clearance test was introduced into medicine by Popper and Mandell in 1937 The results of the other investigations are shown in the table. After 10 days, in all but one patient in each group, the creatinine clearance fell, the average decrease being about 25,, (P<001). At the same time the serum creatinine level rose by an average of about 38", (P<0 01). Most of the change in creatinine clearance occurred in the first three days; the further small decrease in creatinine clearance between day three and day 10 was not statistically significant. These results contrasted considerably with the 5'Cr-edetic acid clearance figures, which showed no significant change.
Discussion
Our results indicate that salicylate treatment was associated with a sustained increase in plasma creatinine levels and a fall in creatinine clearance. Since chromium edetate clearance remained unaffected it is reasonable to assume that these changes did not result from a disturbance of glomerular function, unless salicylate induces a specific interference with filtration of creatinine in the glomerulus. More likely explanations include disturbance of creatinine binding to serum protein or competitive inhibition of tubular secretion of creatinine. The further possibility of abnormal production of creatinine is unlikely as analysis of the daily output of creatinine showed no increase in total excretion. To ensure that the presence of salicylate in plasma had not interfered with the assay of creatinine, salicylate in a concentration of 1 5 mmol 1 (20 mg 100 ml) plasma was added to eight specimens of serum. Assays of creatinine with and without salicylate showed no difference in the results.
Clearly the creatinine clearance test is not suitable for assessing renal function in patients suffering from rheumatoid arthritis since many of these will be receiving salicylate, and the results of the investigations carried out by Sorensen,9 Bulger et al,'" Burry," Jeremy et al, ' and the New Zealand Rheumatism Asso2iation study' 3need to be reassessed in this context. Further studies are indicated to determine whether other drugs have an effect on creatinine clearance similar to that of salicylates and to determine the mode of action of salicylates.
When the creatinine clearance test is used to detect renal disease or monitor progress of renal disease a careful history of the patient's drug-taking habits must be obtained before the results can be assessed.
Introduction
Over the past five years fetal breathing movements in utero have been investigated in sheep and in man' using an ultrasound Nuffield Institute for Medical Research, University of Oxford, Oxford OX3 9DS E S BOYCE, MB, MRCOG, rcscarclh officer G S DAWES, DM, FRS, director J D GOUGH, MB, MRCOG, research officer E R POORE, BSC, research assistant A-scan method, and there is evidence that the continued presence of normal fetal breathing is an index of health.3 The A-scan method, however, requires expensive and complex machines that need considerable practise to use, and it is unsuitable for screening large numbers of patients. We therefore searched for a simple method of detecting fetal breathing movements.
Technique
The maximum velocity of human fetal chest wall movements in utero is only 1-3 cm,s as measured by A-scan ultrasound; this was confirmed using a pulsed Doppler system giving a shift frequency < 70 Hz with a transducer pulsed at 2 MHz.' This shift frequency is rejected by the filtering in most continuous Doppler svstems available clinically.
Nevertheless, audible signals of a character consistent with fetal breathing (fig 1) were obtained using a Sonicaid D205 instrument in more than 70 pregnant women. The validity of this attribution depends, firstly, on the fact that the signal was independent of maternal respiratory movement or pulse rate and of fetal heart rate. When present the signal was within the range 30-90 per minute, was prolonged for more than one fetal heart beat, and was of a rough character-that is, not a pure tone. It was also independent of fetal movements or hiccoughs perceptible to the mother. Alternate use of A-scan and continuous Doppler ultrasound systems in 32 patients showed that the audible signal had the same features as that of fetal breathing
